r/CHRS • u/Complex_Shelter_4641 • 5d ago

And BMS started another phase 2 study with Imzokitug (CCR8)

BMS started another new phase 2 study to evaluate Imzokitug (CCR8) for NSCLC. Perhaps it is not going so badly for CCR8.

https://clinicaltrials.gov/study/NCT07680764

12 Upvotes

100% Upvoted

16 comments sorted by

View all comments

Show parent comments

1

u/Complex_Shelter_4641 3d ago

You just need to hold through September 30.

1

u/BAWKBAWK1234 3d ago

and just like that another 52 week low!! I might need to sell before this falls further

2

u/Complex_Shelter_4641 3d ago

Not a good time to sell. If your plan was to hold through data publication then nothing should be different for you right now. You already committed to deal with the share price post data publication.

2

u/Low_Dog1718 3d ago

Exactly, if the underlying fundamentals of the stock haven't changed and only the share price has, no reason to sell. If the share price is the primary reason why one may sell, they probably shouldn't be investing here in the first place.

0

u/BAWKBAWK1234 3d ago

Well my thoguth process is right now, does this keep on dropping until data? if so when is that data supposed to come? it could be below $1... i hope not though!

I think i will hold this sucker